Ashitaba
Ashitaba is a Japanese herb whose yellow sap chalcones (4-hydroxyderricin, xanthoangelol) have one small positive RCT for visceral fat. One 42-person industry-run trial is not a track record, and the general "longevity herb" marketing has no human support at all.
What the science says
- Reduces visceral fat Limited evidence
A 12-week randomised, double-blind, placebo-controlled trial in 42 overweight adults (BMI 25 to under 30) gave 16 mg/day of ashitaba chalcone (10.1 mg 4-hydroxyderricin plus 5.9 mg xanthoangelol). CT-measured visceral fat area was significantly lower than placebo at 12 weeks and waist circumference at both 8 and 12 weeks (p<0.05). The sample was small, the effect sizes modest, and the study was run by the ingredient supplier — it needs independent replication before this counts as established.
- Extends lifespan or induces autophagy Limited evidence
The longevity claim comes from a 2019 paper showing the ashitaba flavonoid DMC induces autophagy and extends lifespan in yeast, worms and flies, plus cell work. Nothing in humans tests lifespan, healthspan or any autophagy marker, and the doses used in model organisms do not translate to a capsule.
- Improves blood sugar and lipids Limited evidence
Rodent studies report improved insulin sensitivity and lipid profiles with chalcone-rich extracts, but there is no adequately controlled human trial with glycaemic or lipid primary endpoints.
Dosage & safety
Scientific references
Where to buy
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Weight management
- L-Carnitine Moderate evidence
- MCT Oil Moderate evidence
- CLA (Conjugated Linoleic Acid) Limited evidence
- White Kidney Bean Extract Limited evidence
- Glucomannan Limited evidence
- Chitosan Limited evidence